Kodiak Sciences KOD
NASDAQ KOD
$35.36 -1.00 (-2.75%)
As of: Sep 4, 2026 · 3:59 PM EDT

Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026)

Kodiak Sciences' (KOD) quarterly Change in Accured Expenses came in at $4.6 million in Q1 2026, up 93.55% YoY from $2.4 million in Q1 2025, and up 228000.0% on a QoQ basis from -$2000.0 in Q4 2025.

Analysis

Kodiak Sciences (KOD) Change in Accured Expenses (2017 - 2026) Analysis & Trends

Kodiak Sciences (KOD) has 10 years of Change in Accured Expenses data on file, last reported at $4.6 million in Q1 2026.

  • Quarterly Change in Accured Expenses rose 93.55% year-over-year to $4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (up 1913.33% YoY) and the FY2025 annual result came in at $9.3 million, up 225.8% from the prior year.
  • Change in Accured Expenses rose to $4.6 million in Q1 2026, from -$2000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $13.7 million in Q1 2022 to a low of -$12.2 million in Q2 2022.
  • A 5-year average of -$511352.9 and a median of $408000.0 in 2024 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2024 — Change in Accured Expenses plunged 403.28% — and 2025, when it soared 398.59%.
  • Tracing KOD's Change in Accured Expenses over 5 years: stood at -$7.6 million in 2022, then jumped by 39.27% to -$4.6 million in 2023, then jumped by 108.79% to $408000.0 in 2024, then tumbled by 100.49% to -$2000.0 in 2025, then jumped by 228000.0% to $4.6 million in 2026.
  • The last three Change in Accured Expenses figures came in at $4.6 million (Q1 2026), -$2000.0 (Q4 2025), and $5.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Kodiak Sciences 2.21 Bn 2.21 Bn - 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.51 Mn
Mar 31, 2026 4.56 Mn
Dec 31, 2025 -2,000.00
Sep 30, 2025 5.64 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 2.36 Mn
Dec 31, 2024 408,000.00
Sep 30, 2024 1.13 Mn
Jun 30, 2024 -3.32 Mn
Mar 31, 2024 -5.59 Mn
Dec 31, 2023 -4.64 Mn
Sep 30, 2023 -3.99 Mn
Jun 30, 2023 1.10 Mn
Mar 31, 2023 -5.37 Mn
Dec 31, 2022 -7.65 Mn
Sep 30, 2022 3.86 Mn
Jun 30, 2022 -12.15 Mn
Mar 31, 2022 13.70 Mn
Dec 31, 2021 2.96 Mn
Sep 30, 2021 -4.91 Mn